Clinical Trial Update: A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma [Phase 2]

View source ↗

Summary

Phase Ⅱ study of F520 in cervical cancer has completed, reporting early results from a Phase 2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• F520

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED